Site Selection

More Than Location

Selecting the right oncology site is one of the most critical decisions in clinical trial success. Oncology protocols often require highly specific patient populations, experienced investigators, multidisciplinary collaboration, rapid feasibility feedback, and strong access to medical records and referral networks.

BRCR Global supports sponsors and CROs by identifying oncology-ready sites with the infrastructure, investigator engagement, patient access, and operational capacity needed to execute complex studies.

Our site selection process is based on more than location. We evaluate therapeutic experience, investigator profile, patient population, referral pathways, EMR capabilities, competing studies, operational readiness, recruitment feasibility, and site performance potential.

Our Oncology Site Selection Support Includes

• Identification of oncology-ready sites
• Investigator and Sub-Investigator capability review
• Therapeutic area and indication alignment
• Patient population assessment
• EMR and database access evaluation
• Referral network analysis
• Feasibility support and enrollment forecasting
• Site infrastructure and operational readiness review
• Recruitment risk assessment
• Quality and compliance readiness evaluation

Key Oncology Site Selection Criteria

• Access to oncology and hematology patient populations
• Experienced investigators and clinical teams
• Ability to manage complex protocol requirements
• Strong referral relationships with oncologists and specialists
• Capacity for rapid pre-screening and documentation review
• Study team responsiveness and operational discipline
• Commitment to GCP, participant safety, and data integrity

Value for Sponsors and CROs

BRCR Global helps sponsors and CROs select sites that are not only interested in oncology research, but truly prepared to execute it with quality, speed, patient access, and operational accountability.